Suchergebnisse - "Hirata, Haruhiko"

PubPharm (9)

1

Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxel therapy after immunotherapy : a case report

enthalten in: Angiogenesis | 2022

von Matsumoto, K. | Shiroyama, T. | Hashida, N. | +14

2

Lipoid Pneumonia After Pembrolizumab Treatment for Advanced Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2022

von Yaga, M. | Shiroyama, T. | Hirata, H. | +3

3

Monitoring antibody binding to T cells in a pembrolizumab-treated patient with lung adenocarcinoma on hemodialysis

enthalten in: Thoracic cancer | 2019

von Osa, A. | Uenami, T. | Naito, Y. | +13

4

Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors : A preliminary retrospective study

enthalten in: Scientific reports | 2019

von Shiroyama, T. | Nagatomo, I. | Koyama, S. | +13

5

Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models

enthalten in: Biochemical and biophysical research communications | 2017

von Morimura, O. | Minami, T. | Kijima, T. | +13

6

Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2015

von Kinehara, Y. | Minami, T. | Kijima, T. | +14

7

Favorable responses to tocilizumab in two patients with cancer-related cachexia

enthalten in: Journal of pain and symptom management | 2013

von Hirata, H. | Tetsumoto, S. | Kijima, T. | +15

8

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis

enthalten in: Scientific reports | 2013

von Minami, T. | Kijima, T. | Kohmo, S. | +15

9

Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin

enthalten in: Internal medicine (Tokyo, Japan) | 2013

von Nishijima, Y. | Hirata, H. | Himeno, A. | +11

1
[1]